Zhejiang Jiuzhou Pharmaceutical Co Ltd banner
Z

Zhejiang Jiuzhou Pharmaceutical Co Ltd
SSE:603456

Watchlist Manager
Zhejiang Jiuzhou Pharmaceutical Co Ltd
SSE:603456
Watchlist
Price: 17.39 CNY -0.46% Market Closed
Market Cap: ¥15.5B

Income Statement

Earnings Waterfall
Zhejiang Jiuzhou Pharmaceutical Co Ltd

Income Statement
Zhejiang Jiuzhou Pharmaceutical Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Revenue
Interest Expense
0
0
17
0
0
0
13
0
0
0
7
0
0
0
1
0
0
1
4
2
2
3
10
20
30
40
44
42
35
29
25
25
26
25
22
19
18
21
22
25
25
20
19
14
0
0
Revenue
1 269
N/A
1 229
-3%
1 286
+5%
1 325
+3%
1 349
+2%
1 432
+6%
1 445
+1%
1 459
+1%
1 500
+3%
1 559
+4%
1 653
+6%
1 697
+3%
1 694
0%
1 696
+0%
1 717
+1%
1 798
+5%
1 839
+2%
1 752
-5%
1 862
+6%
1 785
-4%
1 801
+1%
1 952
+8%
2 017
+3%
2 010
0%
2 167
+8%
2 404
+11%
2 647
+10%
3 112
+18%
3 507
+13%
3 906
+11%
4 063
+4%
4 581
+13%
5 150
+12%
5 432
+5%
5 445
+0%
5 823
+7%
5 745
-1%
5 649
-2%
5 523
-2%
5 248
-5%
5 033
-4%
4 912
-2%
5 161
+5%
5 175
+0%
5 267
+2%
5 356
+2%
Gross Profit
Cost of Revenue
(916)
(895)
(930)
(954)
(936)
(968)
(981)
(998)
(1 085)
(1 145)
(1 245)
(1 270)
(1 230)
(1 215)
(1 197)
(1 244)
(1 288)
(1 243)
(1 251)
(1 244)
(1 218)
(1 319)
(1 316)
(1 290)
(1 338)
(1 507)
(1 677)
(2 032)
(2 368)
(2 617)
(2 743)
(3 036)
(3 385)
(3 562)
(3 616)
(3 815)
(3 687)
(3 525)
(3 521)
(3 369)
(3 289)
(3 310)
(3 567)
(3 433)
(3 483)
(3 500)
Gross Profit
354
N/A
334
-6%
357
+7%
371
+4%
412
+11%
464
+13%
464
0%
460
-1%
415
-10%
414
0%
409
-1%
426
+4%
464
+9%
481
+4%
521
+8%
555
+7%
551
-1%
509
-8%
612
+20%
541
-12%
583
+8%
633
+9%
701
+11%
720
+3%
829
+15%
898
+8%
971
+8%
1 080
+11%
1 139
+5%
1 288
+13%
1 320
+2%
1 545
+17%
1 765
+14%
1 870
+6%
1 829
-2%
2 008
+10%
2 058
+2%
2 124
+3%
2 003
-6%
1 879
-6%
1 744
-7%
1 602
-8%
1 594
0%
1 743
+9%
1 784
+2%
1 856
+4%
Operating Income
Operating Expenses
(190)
(178)
(208)
(220)
(256)
(280)
(266)
(272)
(276)
(283)
(308)
(320)
(309)
(321)
(319)
(321)
(363)
(365)
(385)
(385)
(360)
(366)
(388)
(413)
(461)
(442)
(462)
(504)
(499)
(573)
(566)
(670)
(828)
(840)
(770)
(847)
(812)
(839)
(883)
(848)
(805)
(824)
(861)
(1 034)
(984)
(993)
Selling, General & Administrative
(182)
(174)
(125)
(213)
(253)
(274)
(165)
(270)
(257)
(265)
(174)
(298)
(306)
(318)
(187)
(317)
(318)
(305)
(243)
(296)
(271)
(272)
(225)
(312)
(377)
(356)
(288)
(381)
(345)
(398)
(335)
(432)
(523)
(527)
(450)
(506)
(497)
(514)
(538)
(543)
(483)
(480)
(517)
(513)
(507)
(491)
Research & Development
0
0
(55)
0
0
0
(77)
0
0
0
(76)
0
0
0
(85)
0
0
(21)
(80)
(63)
(88)
(91)
(88)
(96)
(98)
(105)
(101)
(132)
(152)
(160)
(156)
(202)
(258)
(279)
(257)
(302)
(288)
(300)
(284)
(317)
(324)
(331)
(277)
(318)
(283)
(270)
Depreciation & Amortization
0
0
(26)
0
0
0
(38)
0
0
0
(56)
0
0
0
(62)
0
0
0
(75)
0
0
0
(96)
0
0
0
(111)
0
0
0
(103)
0
0
0
(97)
0
0
0
(107)
0
0
0
(111)
0
0
0
Other Operating Expenses
(8)
(4)
(3)
(7)
(3)
(6)
14
(2)
(19)
(18)
(2)
(22)
(3)
(2)
15
(4)
(45)
(39)
13
(27)
(1)
(3)
21
(5)
15
19
38
10
(2)
(15)
28
(36)
(47)
(34)
34
(39)
(27)
(25)
45
12
2
(13)
44
(204)
(194)
(232)
Operating Income
164
N/A
156
-5%
149
-5%
151
+1%
157
+4%
185
+18%
198
+7%
188
-5%
139
-26%
132
-5%
101
-23%
106
+6%
155
+46%
160
+3%
202
+26%
233
+16%
188
-19%
144
-23%
227
+57%
156
-31%
223
+43%
266
+20%
313
+18%
308
-2%
369
+20%
456
+24%
509
+12%
577
+13%
641
+11%
715
+12%
753
+5%
874
+16%
937
+7%
1 030
+10%
1 059
+3%
1 161
+10%
1 246
+7%
1 285
+3%
1 120
-13%
1 031
-8%
939
-9%
778
-17%
733
-6%
708
-3%
800
+13%
863
+8%
Pre-Tax Income
Interest Income Expense
(13)
(12)
(24)
(18)
23
28
10
28
7
3
18
14
3
(6)
(24)
(39)
5
11
(21)
33
(10)
(23)
(21)
(34)
(39)
(39)
(50)
(48)
(11)
7
24
29
50
54
55
48
24
38
60
80
82
62
67
57
33
40
Non-Reccuring Items
0
0
0
0
0
0
10
0
0
0
(3)
0
0
0
(3)
(2)
(3)
(4)
(12)
(3)
(3)
(2)
(7)
(0)
(1)
2
(3)
(2)
(6)
(10)
(24)
(9)
(7)
(6)
(6)
(5)
(3)
(4)
(1)
(5)
(5)
(3)
(69)
(1)
(2)
(5)
Gain/Loss on Disposition of Assets
0
(0)
6
(3)
(4)
(8)
(9)
(6)
(5)
(1)
0
(0)
(2)
(1)
0
0
0
0
0
0
0
0
(5)
0
0
0
(5)
0
0
0
(9)
0
0
0
(4)
0
0
0
(1)
0
0
0
(2)
0
0
0
Total Other Income
29
37
28
39
30
26
23
17
7
6
16
17
12
7
(1)
(3)
(1)
(1)
(1)
(1)
(0)
0
7
1
(0)
(7)
(1)
(7)
(11)
(3)
(0)
(9)
(4)
(6)
(0)
(2)
1
0
4
5
2
2
0
(2)
(5)
(4)
Pre-Tax Income
180
N/A
181
+1%
158
-13%
169
+7%
205
+21%
230
+12%
231
+0%
227
-2%
147
-35%
139
-6%
133
-5%
137
+4%
168
+22%
160
-5%
174
+9%
187
+8%
190
+1%
151
-21%
193
+28%
185
-4%
210
+13%
241
+15%
287
+19%
274
-4%
328
+20%
412
+25%
450
+9%
519
+15%
613
+18%
710
+16%
745
+5%
885
+19%
976
+10%
1 072
+10%
1 104
+3%
1 201
+9%
1 268
+6%
1 320
+4%
1 181
-11%
1 111
-6%
1 018
-8%
839
-18%
731
-13%
761
+4%
826
+9%
894
+8%
Net Income
Tax Provision
(23)
(24)
(20)
(23)
(33)
(33)
(31)
(30)
(21)
(21)
(21)
(22)
(22)
(22)
(28)
(31)
(28)
(23)
(37)
(38)
(40)
(44)
(50)
(48)
(64)
(71)
(70)
(77)
(87)
(96)
(111)
(138)
(149)
(170)
(183)
(209)
(194)
(177)
(149)
(123)
(132)
(140)
(124)
(140)
(168)
(171)
Income from Continuing Operations
157
156
137
146
172
197
200
197
126
118
111
116
146
139
147
156
162
127
156
148
170
197
237
226
264
341
380
442
526
614
634
747
827
902
921
993
1 074
1 144
1 031
988
886
700
607
621
658
723
Income to Minority Interest
(2)
(1)
(4)
(3)
(2)
(3)
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
0
0
0
(0)
0
(0)
2
0
1
1
1
2
1
1
(2)
(1)
(1)
(1)
(0)
Net Income (Common)
155
N/A
156
+0%
133
-14%
142
+7%
170
+20%
195
+15%
200
+3%
197
-1%
126
-36%
118
-7%
112
-5%
116
+4%
147
+27%
139
-5%
148
+6%
157
+6%
163
+4%
129
-21%
157
+22%
149
-5%
171
+15%
198
+16%
238
+20%
227
-5%
265
+17%
342
+29%
381
+11%
443
+16%
526
+19%
614
+17%
634
+3%
747
+18%
827
+11%
904
+9%
921
+2%
994
+8%
1 075
+8%
1 144
+7%
1 033
-10%
989
-4%
887
-10%
697
-21%
606
-13%
620
+2%
657
+6%
723
+10%
EPS (Diluted)
0.29
N/A
0.29
N/A
0.22
-24%
0.18
-18%
0.24
+33%
0.26
+8%
0.27
+4%
0.24
-11%
0.17
-29%
0.15
-12%
0.14
-7%
0.14
N/A
0.18
+29%
0.17
-6%
0.19
+12%
0.19
N/A
0.2
+5%
0.16
-20%
0.2
+25%
0.19
-5%
0.21
+11%
0.24
+14%
0.3
+25%
0.28
-7%
0.33
+18%
0.43
+30%
0.47
+9%
0.51
+9%
0.64
+25%
0.74
+16%
0.76
+3%
0.9
+18%
0.99
+10%
1.08
+9%
1.11
+3%
1.13
+2%
1.19
+5%
1.3
+9%
1.16
-11%
1.1
-5%
0.99
-10%
0.77
-22%
0.68
-12%
0.69
+1%
0.73
+6%
0.81
+11%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett